News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Serine Racemase Upregulation Improves Learning and Synaptic Function

Aging

April 19, 2023
PRESS RELEASE: A new research paper was published in Aging's Volume 15, Issue 7, entitled, “Viral vector-mediated upregulation of serine racemase expression in medial prefrontal cortex improves learning and synaptic function in middle age rats.” continue reading »

CA 19-9 and CEA in Prognosis of Duodenal Adenocarcinoma: A Retrospective Study

News

April 18, 2023
PRESS RELEASE: On April 15, 2023, a new research paper was published in Oncotarget, entitled, “Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study.” continue reading »

Cancer Prevention With Rapamycin

News

April 17, 2023
PRESS RELEASE: On April 14, 2023, a new research perspective was published in Oncotarget, entitled, “Cancer prevention with rapamycin.” continue reading »

p21 Facilitates Chronic Lung Inflammation via Epithelial and Endothelial Cells

Aging

April 17, 2023
PRESS RELEASE: A new research paper was published on the cover of Aging's Volume 15, Issue 7, entitled, “p21 facilitates chronic lung inflammation via epithelial and endothelial cells.” continue reading »

Riluzole and Sorafenib in Patients With Advanced Solid Tumors: A Phase I Trial 

News

April 12, 2023
PRESS RELEASE: On April 10, 2023, a new research paper was published in Oncotarget, entitled, “A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850.” continue reading »